Trout Capital Advisors Serves as Exclusive Financial Advisor to Universal Plastics & Engineering Company in Sale to UFP Technologies
UFP Technologies (NASDAQ:UFPT) has acquired Universal Plastics & Engineering Company (UNIPEC), a Maryland-based manufacturer of precision thermoformed and heat-sealed polymer components for medical devices. UNIPEC specializes in producing components for battery shielding in Class III implantable medical devices.
The acquisition strengthens UFP Technologies' presence in the medical manufacturing sector. UNIPEC, a family-owned business since 1957, brings valuable capabilities and customer relationships to UFP's expanding medical-focused portfolio. Trout Capital Advisors served as the exclusive financial advisor to UNIPEC in this transaction.
UFP Technologies (NASDAQ:UFPT) ha acquisito Universal Plastics & Engineering Company (UNIPEC), un produttore del Maryland specializzato in componenti polimerici termoformati di precisione e sigillati a caldo per dispositivi medici. UNIPEC è esperta nella produzione di componenti per la schermatura delle batterie in dispositivi medici impiantabili di Classe III.
Questa acquisizione rafforza la presenza di UFP Technologies nel settore della produzione medica. UNIPEC, un’azienda a conduzione familiare dal 1957, apporta competenze preziose e relazioni consolidate con i clienti al portafoglio in espansione di UFP focalizzato sul settore medico. Trout Capital Advisors ha agito come consulente finanziario esclusivo di UNIPEC in questa operazione.
UFP Technologies (NASDAQ:UFPT) ha adquirido Universal Plastics & Engineering Company (UNIPEC), un fabricante de Maryland especializado en componentes poliméricos termoformados y sellados con calor para dispositivos médicos. UNIPEC se especializa en la producción de componentes para la protección de baterÃas en dispositivos médicos implantables de Clase III.
La adquisición fortalece la presencia de UFP Technologies en el sector de fabricación médica. UNIPEC, una empresa familiar desde 1957, aporta capacidades valiosas y relaciones con clientes al portafolio en expansión de UFP enfocado en el sector médico. Trout Capital Advisors actuó como asesor financiero exclusivo de UNIPEC en esta transacción.
UFP Technologies (NASDAQ:UFPT)ê°€ 메릴랜드ì—� 기반ì� ë‘� ì •ë°€ 열성í˜� ë°� ì—´ë°€ë´� í´ë¦¬ë¨� ì˜ë£Œê¸°ê¸° ë¶€í’� ì œì¡°ì—…ì²´ì� Universal Plastics & Engineering Company (UNIPEC)ë¥� ì¸ìˆ˜í–ˆìŠµë‹ˆë‹¤. UNIPECëŠ� í´ëž˜ìŠ� III ì´ì‹í˜� ì˜ë£Œê¸°ê¸°ì� ë°°í„°ë¦� ì°¨íìš� ë¶€í’� ìƒì‚°ì� ì „ë¬¸ìœ¼ë¡œ 합니ë‹�.
ì´ë²ˆ ì¸ìˆ˜ë¡� UFP TechnologiesëŠ� ì˜ë£Œ ì œì¡° 분야ì—서 ìž…ì§€ë¥� 강화하게 ë˜ì—ˆìŠµë‹ˆë‹�. 1957ë…„ë¶€í„� ê°€ì¡� ê²½ì˜í•´ì˜¨ UNIPECëŠ� UFPì� 확대 ì¤‘ì¸ ì˜ë£Œ 중심 í¬íЏí´ë¦¬ì˜¤ì— 귀중한 ì—량ê³� ê³ ê° ê´€ê³„ë¥¼ ì œê³µí•©ë‹ˆë‹�. Trout Capital AdvisorsëŠ� ì´ë²ˆ 거래ì—서 UNIPECì� ë…ì 금융 ìžë¬¸ì� 맡았습니ë‹�.
UFP Technologies (NASDAQ:UFPT) a acquis Universal Plastics & Engineering Company (UNIPEC), un fabricant basé dans le Maryland spécialisé dans les composants polymères thermoformés de précision et scellés à chaud pour dispositifs médicaux. UNIPEC est spécialisé dans la production de composants pour la protection des batteries dans les dispositifs médicaux implantables de Classe III.
Cette acquisition renforce la présence de UFP Technologies dans le secteur de la fabrication médicale. UNIPEC, une entreprise familiale depuis 1957, apporte des compétences précieuses et des relations clients solides au portefeuille médical en expansion de UFP. Trout Capital Advisors a agi en tant que conseiller financier exclusif de UNIPEC pour cette transaction.
UFP Technologies (NASDAQ:UFPT) hat Universal Plastics & Engineering Company (UNIPEC), einen in Maryland ansässigen Hersteller von präzisionsgeformten und wärmeversiegelten Polymerkomponenten für medizinische Geräte, übernommen. UNIPEC ist spezialisiert auf die Herstellung von Komponenten für Batterieschutz in implantierbaren Medizinprodukten der Klasse III.
Die Übernahme stärkt die Präsenz von UFP Technologies im medizinischen Fertigungssektor. UNIPEC, ein familiengeführtes Unternehmen seit 1957, bringt wertvolle Fähigkeiten und Kundenbeziehungen in das wachsende, medizinisch fokussierte Portfolio von UFP ein. Trout Capital Advisors fungierte als exklusiver Finanzberater von UNIPEC bei dieser Transaktion.
- Strategic expansion into Class III implantable medical device components
- Acquisition adds precision thermoforming and heat-sealing capabilities
- Gains established customer relationships in medical device sector
- None.
Insights
UFP Technologies strengthens medical device manufacturing capabilities by acquiring UNIPEC, expanding its specialized polymer components portfolio.
UFP Technologies (UFPT) has acquired Universal Plastics & Engineering Company (UNIPEC), a specialized manufacturer of precision thermoformed and heat-sealed polymer components primarily used for battery shielding in Class III implantable medical devices. This acquisition strategically enhances UFP's portfolio in the high-value medical manufacturing sector.
UNIPEC, based in Rockville, Maryland, brings valuable capabilities in specialized polymer components for critical medical applications. The company has been family-owned since 1957, suggesting a stable operation with established customer relationships and manufacturing expertise. The focus on components for Class III implantable devices—the FDA's highest-risk classification requiring premarket approval—indicates UNIPEC operates in a highly regulated, specialized market segment with significant barriers to entry.
This acquisition aligns with UFP's strategic focus on the medical market, where specialized manufacturing capabilities and established customer relationships are particularly valuable. For UFP investors, this represents a capability expansion in precision polymer components for critical medical applications, potentially strengthening the company's competitive position in high-margin medical device manufacturing.
While financial terms weren't disclosed, acquisitions of specialized medical manufacturing operations typically command premium valuations due to their technical expertise, regulatory compliance infrastructure, and established customer relationships with medical device manufacturers. The acquisition of a company with a 65+ year operating history suggests UFP is gaining established manufacturing processes and customer relationships rather than speculative or early-stage technology.
Headquartered in
Andrew Rice, Managing Partner at Trout Capital Advisors, commented:
"We were honored to represent UNIPEC in this transaction. This deal represents a strong strategic outcome for the company, and we're proud to have helped facilitate UNIPEC's next chapter as part of UFP Technologies."
Said Brandt Berghers, President of UNIPEC: "This business has been in my family since 1957. The team at Trout Capital Advisors understood the importance of legacy, respect for our customers, and future opportunities for my employees. This outcome is beyond anything I could have imagined, and I am delighted to see UNIPEC join the UFP family."
This transaction highlights Trout Capital Advisors' continued momentum and expertise in advising privately held businesses in the advanced manufacturing and engineered products sectors.
Stephen Gierasch of McNees Wallace & Nurick served as legal counsel to UNIPEC.
About Trout Capital Advisors
Trout Capital Advisors, LLC is a boutique investment banking firm that exclusively serves lower-middle market businesses, with a focus on founder- and family-owned companies. With deep transactional experience and a client-centered approach, the firm delivers tailored advisory solutions that help owners achieve successful outcomes during one of the most significant events in their business lives.
Media Contact:
Andrew Rice
Managing Partner
Trout Capital Advisors, LLC
[email protected]ÌýÌý
Ìý
View original content:
SOURCE Trout Capital Advisors